We are live on
!
Find out more
PC
Pavadi Capital Portfolio holdings
AUM
$81.2M
1-Year Est. Return
5.26%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.2M
AUM Growth
+$4.4M
(+5.7%)
Cap. Flow
+$743K
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
82.59%
Holding
19
New
3
Increased
5
Reduced
6
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$8.03M |
| 2 |
Zimmer Biomet
ZBH
|
+$6.19M |
| 3 |
Baxter International
BAX
|
+$4.65M |
| 4 |
UnitedHealth
UNH
|
+$4.03M |
| 5 |
HCA Healthcare
HCA
|
+$3.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PINC
Premier
PINC
|
+$5.17M |
| 2 |
Cardinal Health
CAH
|
+$5.06M |
| 3 |
InMode
INMD
|
+$4.73M |
| 4 |
Integra LifeSciences
IART
|
+$3.82M |
| 5 |
Envista
NVST
|
+$3.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Elevance Health
ELV
$81.9B
| $8.19M | 10.09% |
+17,374
| New | +$8.03M |
|
|
2
UnitedHealth
UNH
$380B
| $8.04M | 9.9% |
15,271
+7,560
| +98% | +$4.03M |
|
|
3
HCA Healthcare
HCA
$87B
| $7.56M | 9.31% |
27,927
+12,216
| +78% | +$3.02M |
|
4
Molina Healthcare
MOH
$10.2B
| $6.89M | 8.49% |
19,079
-2,261
| -11% | -$797K |
|
5
Centene
CNC
$30.8B
| $6.85M | 8.44% |
92,349
+27,958
| +43% | +$2.02M |
|
6
CVS Health
CVS
$134B
| $6.76M | 8.32% |
85,580
+29,562
| +53% | +$2.1M |
|
|
7
Zimmer Biomet
ZBH
$18.2B
| $6.76M | 8.32% |
+55,515
| New | +$6.19M |
|
8
Humana
HUM
$44B
| $6.35M | 7.83% |
13,878
+6,056
| +77% | +$2.98M |
|
|
9
Baxter International
BAX
$13.5B
| $5.08M | 6.25% |
+131,315
| New | +$4.65M |
|
|
PDCO
10
DELISTED
Patterson Companies, Inc.
PDCO
| $4.56M | 5.61% |
160,155
-23,972
| -13% | -$706K |
|
11
GE HealthCare
GEHC
$30.8B
| $4.37M | 5.39% |
56,560
-22,928
| -29% | -$1.61M |
|
12
QuidelOrtho
QDEL
$1.15B
| $3.74M | 4.61% |
50,752
-10,211
| -17% | -$690K |
|
13
Tenet Healthcare
THC
$20.3B
| $3.51M | 4.32% |
46,433
-46,234
| -50% | -$2.93M |
|
14
Lantheus
LNTH
$6.5B
| $2.51M | 3.09% |
40,492
-45,102
| -53% | -$3.06M |
|
|
15
Cardinal Health
CAH
$53.9B
| – | – |
-58,331
| Closed | -$5.06M |
|
|
16
Integra LifeSciences
IART
$1.29B
| – | – |
-99,999
| Closed | -$3.82M |
|
|
17
InMode
INMD
$871M
| – | – |
-155,217
| Closed | -$4.73M |
|
|
18
Envista
NVST
$4.46B
| – | – |
-133,299
| Closed | -$3.72M |
|
|
PINC
19
DELISTED
Premier
PINC
| – | – |
-240,681
| Closed | -$5.17M |
|
Similar funds
BAM
TCM
JAM
HH
CPI
SLM
AFG
TIMH
Pavadi Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Pavadi Capital held 19 positions worth $81.2M, up 5.7% from $76.8M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Pavadi Capital's Q4 2023 filing shows 3 new, 5 increased, 6 reduced and 5 closed positions. Its largest new stake was Elevance Health: 17,374 shares worth $8.19M. The largest sale was Premier, an estimated $5.17M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Pavadi Capital's largest Q4 2023 buy was Elevance Health: 17,374 shares worth $8.19M.
- Pavadi Capital added most to UnitedHealth in Q4 2023, an estimated $4.03M increase.
- Pavadi Capital's biggest Q4 2023 reduction was Lantheus, cutting an estimated $3.06M.
- Pavadi Capital fully exited Premier in Q4 2023, selling an estimated $5.17M.
- Pavadi Capital's ten largest holdings make up 83% of its $81.2M portfolio in Q4 2023.
- Pavadi Capital opened 3 new positions and closed 5 in Q4 2023.
- Pavadi Capital's portfolio value rose 5.7% quarter-over-quarter to $81.2M.
Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.